Safety of Antibacterial and Antiprotozoal Medicinal Products

Safety of Antibacterial and Antiprotozoal Medicinal Products

The experts of the Scientific Centre for Expert Evaluation of Medicinal Products analysed administrative decisions of foreign regulatory authorities on the recalls of antibacterial and antiprotozoal medicinal products and/or the need for labelling updates due to changes in the safety profile. The an...

Full description

Bibliographic Details
Main Authors:	E. V. Shubnikova, T. M. Bukatina, A. A. Druzhinina, E. O. Zhuravleva, G. V. Kutekhova, N. Yu. Velts
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-07-01
Series:	Безопасность и риск фармакотерапии
Subjects:	adverse drug reactions post-marketing studies safety profile medicinal products antibacterials antiprotozoals labelling pharmacovigilance
Online Access:	https://www.risksafety.ru/jour/article/view/299

Similar Items

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018-09-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

Drug Safety Monitoring Information
by: Elena V. Shubnikova, et al.
Published: (2020-06-01)

In vitro regeneration of Stevia and evaluation of antimicrobial and antiprotozoal properties of regenerated calli and plants
by: Arvind Arya, Sandeep Kumar, and M.S. Kasana
Published: (2012-09-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Critical Overview of the Contents of Risk Management Plans for Medicines
by: T. M. Bukatina, et al.
Published: (2022-04-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
by: Abdulaziz L, et al.
Published: (2022-03-01)

ANTIMICROBIAL AND ANTIPROTOZOAL EFFECT OF SWEET MARJORAM (Origanum majorana L.)
by: Mariola Kozłowska, et al.
Published: (2010-12-01)

Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021-12-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

Peroxides with Anthelmintic, Antiprotozoal, Fungicidal and Antiviral Bioactivity: Properties, Synthesis and Reactions
by: Vera A. Vil’, et al.
Published: (2017-11-01)

Synthesis and Antiprotozoal Profile of 3,4,5‐Trisubstituted Isoxazoles
by: Prof. Fernanda Andreia Rosa, et al.
Published: (2021-10-01)

Natural marine products as antiprotozoal agents against amitochondrial parasites
by: Edgar Antonio Estrella-Parra, et al.
Published: (2022-08-01)

Comparative Analysis of Drug Interactions with Antibacterial Agents in the Treatment of Community-Acquired Pneumonia
by: A. A. Taube, et al.
Published: (2021-10-01)

HPLC-Based Activity Profiling for Antiprotozoal Compounds in Croton gratissimus and Cuscuta hyalina
by: Abdelhalim Babiker Mahmoud, et al.
Published: (2020-08-01)

Signal Messages in Pediatric Practice
by: G. V. Kutekhova, et al.
Published: (2018-12-01)

Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020-09-01)

Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice
by: N. Yu. Velts, et al.
Published: (2023-03-01)

Pharmacovigilance Activities in Maulana Azad Medical College and Associated Hospitals: A Step towards Patient Safety
by: Vandana Roy, et al.
Published: (2023-01-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Assessment of the in Vitro Antiprotozoal and Cytotoxic Potential of 20 Selected Medicinal Plants from the Island of Soqotra
by: Louis Maes, et al.
Published: (2012-12-01)

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study
by: Elaaf Fadhil Hassan, et al.
Published: (2022-06-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Antiprotozoal and Antitumor Activity of Natural Polycyclic Endoperoxides: Origin, Structures and Biological Activity
by: Valery M. Dembitsky, et al.
Published: (2021-01-01)

Quantitative Structure ‒ Antiprotozoal Activity Relationships of Sesquiterpene Lactones
by: Reto Brun, et al.
Published: (2009-06-01)

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities
by: Elena V. Shubnikova, et al.
Published: (2020-03-01)

Antiprotozoal Effect of Snake Venoms and Their Fractions: A Systematic Review
by: Zainab U. Abdullahi, et al.
Published: (2021-12-01)

Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
by: E. V. Shubnikova, et al.
Published: (2020-03-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Pharmacological Assessment of the Antiprotozoal Activity, Cytotoxicity and Genotoxicity of Medicinal Plants Used in the Treatment of Malaria in the Greater Mpigi Region in Uganda
by: Fabien Schultz, et al.
Published: (2021-06-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)